NCT07429890Not yet recruiting
REVIVE Prospective Registry Cohort Study
Prospective Observational Long-Term Safety and Effectiveness Registry of Patients Who Have Received Iltamiocel as Part of REVIVE Clinical Study in Patients With Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 31 (estimated)
- First submitted
- 24 Jan 2026
- Start date
- 30 Aug 2026
- Primary completion date
- 30 Jun 2031
- Lead sponsor
- University of California, Davis
- Diseases
- Head and neck cancer
- NCT number
- NCT07429890
What you commit to
- Study type: Observational
- Planned participants: 31
- From 30 Aug 2026 to the primary completion date, 30 Jun 2031
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The following criteria will exclude participants from participation:
- Has received placebo as part of the blinded portion of the REVIVE study.
- Unable or unwilling to provide informed consent.
- Not available for, or willing to comply with the follow-up evaluations as required by the protocol.
Who the study is looking for
- Participants who have received iltamiocel as part of participation in the REVIVE clinical study for males and females with tongue dysphagia (TD) are eligible, provided the following criteria are fulfilled:
- Has completed the Month 24 visit in the REVIVE study.
- Has received iltamiocel as part of the blinded portion of the REVIVE study.
- Must be willing and able to comply with the study procedures, is able to understand all study requirements and must agree to read and sign the informed consent form prior to any study-related procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UC Davis Medical Center Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
| UC SanFrancisco Medical Center Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.